Peil, Barbara
Boehringer Ingelheim (Germany)
2 papers on CoChat
Most cited papers
- Verified
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
Abraham, W. T., Lindenfeld, J., Ponikowski, P., Agostoni, P., Butler, J., Desai, A. S., Filippatos, G., Gniot, J., Fu, M., Gullestad, L., et al. (2021) · European Heart Journal
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 217
- Verified
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial
Butler, J., Anker, S. D., Filippatos, G., Khan, M. S., Ferreira, J. P., Pocock, S. J., Giannetti, N., Januzzi, J. L., Piña, I. L., Lam, C. S. P., et al. (2021) · European Heart Journal
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 183
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free